|Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology|
K Brudey, JR Driscoll, L Rigouts, WM Prodinger, A Gori, SA Al-Hajoj, ...
BMC microbiology 6 (1), 1-17, 2006
|Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment|
A van Rie, R Warren, M Richardson, TC Victor, RP Gie, DA Enarson, ...
New England Journal of Medicine 341 (16), 1174-1179, 1999
|The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis|
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
|Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis|
S Verver, RM Warren, N Beyers, M Richardson, GD Van Der Spuy, ...
American journal of respiratory and critical care medicine 171 (12), 1430-1435, 2005
|Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage|
M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ...
Nature genetics 47 (3), 242-249, 2015
|Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions|
NC Gey van Pittius, SL Sampson, H Lee, Y Kim, PD Van Helden, ...
BMC evolutionary biology 6 (1), 1-31, 2006
|Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis|
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
|Patients with active tuberculosis often have different strains in the same sputum specimen|
RM Warren, TC Victor, EM Streicher, M Richardson, N Beyers, ...
American journal of respiratory and critical care medicine 169 (5), 610-614, 2004
|Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting|
G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ...
American journal of respiratory and critical care medicine 184 (1), 132-140, 2011
|Drug resistance in Mycobacterium tuberculosis|
R Johnson, EM Streicher, GE Louw, RM Warren, PD Van Helden, ...
Current issues in molecular biology 8 (2), 97-112, 2006
|Novel Mycobacterium tuberculosis complex pathogen, M. mungi|
KA Alexander, PN Laver, AL Michel, M Williams, PD van Helden, ...
Emerging infectious diseases 16 (8), 1296, 2010
|Proportion of tuberculosis transmission that takes place in households in a high-incidence area|
S Verver, RM Warren, Z Munch, M Richardson, GD van der Spuy, ...
The Lancet 363 (9404), 212-214, 2004
|Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference|
RM Warren, NC Gey van Pittius, M Barnard, A Hesseling, E Engelke, ...
The International Journal of Tuberculosis and Lung Disease 10 (7), 818-822, 2006
|Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa|
M Klopper, RM Warren, C Hayes, NCG van Pittius, EM Streicher, B Müller, ...
Emerging infectious diseases 19 (3), 449, 2013
|Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis|
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
|A balancing act: efflux/influx in mycobacterial drug resistance|
GE Louw, RM Warren, NC Gey van Pittius, CRE McEvoy, PD Van Helden, ...
Antimicrobial agents and chemotherapy 53 (8), 3181-3189, 2009
|Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study|
K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ...
The Lancet 375 (9728), 1798-1807, 2010
|Bacille Calmette-Guérin vaccine—induced disease in HIV-infected and HIV-uninfected children|
AC Hesseling, H Rabie, BJ Marais, M Manders, M Lips, HS Schaaf, ...
Clinical infectious diseases 42 (4), 548-558, 2006
|A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis|
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
|Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study|
E Pietersen, E Ignatius, EM Streicher, B Mastrapa, X Padanilam, A Pooran, ...
The Lancet 383 (9924), 1230-1239, 2014